Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Consummate Capital
New York, New York, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Consummate Capital is a private investment and advisory firm focused on the pharmaceutical sector. Public descriptions indicate the firm sources and structures acquisitions of generic and branded pharmaceutical products for clients rather than operating as a drug developer with an internal R&D pipeline. The firm appears to be based in New York City and is associated publicly with managing partner Harsha Murthy, a pharmaceutical and finance executive. Based on the limited public record available, Consummate Capital is healthcare-related as an investor and strategic advisor, but it does not appear to be a biotech or pharma company with disclosed therapeutic programs.
- Industry
- Investors
Beyond the preview
Go deeper on Consummate Capital.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Consummate Capital.